|
SPIN4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.6180999999933E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.361400E-04 |
| Normal-vs-Stage2 |
2.002500E-03 |
| Normal-vs-Stage3 |
1.049680E-04 |
| Normal-vs-Stage4 |
5.80209999999637E-05 |
| Stage1-vs-Stage2 |
5.631400E-01 |
| Stage1-vs-Stage3 |
3.614800E-01 |
| Stage1-vs-Stage4 |
8.340300E-02 |
| Stage2-vs-Stage3 |
9.362600E-01 |
| Stage2-vs-Stage4 |
3.776800E-01 |
| Stage3-vs-Stage4 |
3.193000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.96950000000463E-05 |
| Normal-vs-AfricanAmerican |
6.594300E-02 |
| Normal-vs-Asian |
1.074110E-02 |
| Caucasian-vs-AfricanAmerican |
6.166600E-01 |
| Caucasian-vs-Asian |
6.694000E-01 |
| AfricanAmerican-vs-Asian |
8.864600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.006600E-04 |
| Normal-vs-Female |
9.96530000000329E-05 |
| Male-vs-Female |
8.435800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.762000E-03 |
| Normal-vs-Age(41-60Yrs) |
3.70069999999778E-05 |
| Normal-vs-Age(61-80Yrs) |
4.17609999999735E-05 |
| Normal-vs-Age(81-100Yrs) |
1.674780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.894300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.015770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.868000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.083600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.893600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.337200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.677600E-02 |
| Classical-VS-Follicular |
1.217610E-01 |
| Classical-VS-Other |
9.111200E-01 |
| Classical-VS-Normal |
9.575400E-04 |
| Tall-VS-Follicular |
5.585600E-01 |
| Tall-VS-Other |
4.616600E-01 |
| Tall-VS-Normal |
3.837300E-04 |
| Follicular-VS-Other |
7.152000E-01 |
| Follicular-VS-Normal |
3.226400E-04 |
| Other-VS-Normal |
1.807380E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.82729999999421E-05 |
| Normal-vs-N1 |
7.171600E-04 |
| N0-vs-N1 |
9.834400E-01 |
|
|
